Journals / Diagnostic and Interventional Radiology / 2019 / Cilt: 25 - Sayı: 3

Ultra-low dose contrast CT pulmonary angiography in oncology patients using a high-pitch helical dual-source technology

Pages
195–203
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Attenuation, noise, and signal-to-noise ratio (SNR) were measured in multiple pulmonary arteries.Three independent readers graded the images on a 5-point Likert scale for central vascular enhancement (CVE), peripheral vascular enhancement (PVE), and overall quality.RESULTSThere were 50 males and 101 females in our study.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSEWe aimed to determine if the image quality and vascular enhancement are preserved in computed tomography pulmonary angiography (CTPA) studies performed with ultra-low contrastand optimized radiation dose using high-pitch helical mode of a second generation dual sourcescanner.METHODSWe retrospectively evaluated oncology patients who had CTPA on a 128-slice dual-source scanner, with a high-pitch helical mode (3.0), following injection of 30 mL of Ioversal at 4 mL/s withbody mass index (BMI) dependent tube potential (80–120 kVp) and current (130–150 mAs).
📊
Key Findings & Data:Attenuation, noise, and signal-to-noise ratio (SNR) were measured in multiple pulmonary arteries.Three independent readers graded the images on a 5-point Likert scale for central vascular enhancement (CVE), peripheral vascular enhancement (PVE), and overall quality.RESULTSThere were 50 males and 101 females in our study.
💡
Conclusion & Impact:The average radiation dose length product (DLP) was 161±60 mGy.cm.CONCLUSIONUsing a helical high-pitch acquisition technique, CTPA images of excellent diagnostic quality,including visualization of peripheral segmental/sub-segmental branches can be obtained usingan ultra-low dose of iodinated contrast and low radiation dose.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

PURPOSEWe aimed to determine if the image quality and vascular enhancement are preserved in computed tomography pulmonary angiography (CTPA) studies performed with ultra-low contrastand optimized radiation dose using high-pitch helical mode of a second generation dual sourcescanner.METHODSWe retrospectively evaluated oncology patients who had CTPA on a 128-slice dual-source scanner, with a high-pitch helical mode (3.0), following injection of 30 mL of Ioversal at 4 mL/s withbody mass index (BMI) dependent tube potential (80–120 kVp) and current (130–150 mAs). Attenuation, noise, and signal-to-noise ratio (SNR) were measured in multiple pulmonary arteries.Three independent readers graded the images on a 5-point Likert scale for central vascular enhancement (CVE), peripheral vascular enhancement (PVE), and overall quality.RESULTSThere were 50 males and 101 females in our study. BMI ranged from 13 to 38 kg/m2 (22.8±4.4kg/m2). Pulmonary embolism was present in 29 patients (18.9%). Contrast enhancement andSNR were excellent in all the pulmonary arteries (395.3±131.1 and 18.3±5.7, respectively). Imagequality was considered excellent by all the readers, with average reader scores near the highestpossible score of 5.0 (CVE, 4.83±0.48; PVE, 4.68±0.65; noise/quality, 4.78±0.47). The average radiation dose length product (DLP) was 161±60 mGy.cm.CONCLUSIONUsing a helical high-pitch acquisition technique, CTPA images of excellent diagnostic quality,including visualization of peripheral segmental/sub-segmental branches can be obtained usingan ultra-low dose of iodinated contrast and low radiation dose.

🔖

Cite This Article

RAJİAH, P., CIANCIBELLO, L., NOVAK, R., SPOSATO, J., LANDERAS, L., GILKESON, R. (2019). Ultra-low dose contrast CT pulmonary angiography in oncology patients using a high-pitch helical dual-source technology. Diagnostic and Interventional Radiology, Cilt: 25 - Sayı: 3, 195–203. https://ajindex.com/articles/350011

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: A population based case-control study. Arch Intern Med 2000
  2. 809–815. [CrossRef] 2. Heit JA, O'Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population based study. Arch Intern Med 2002
  3. 1245– 1248. [CrossRef] 3. Thodiyil PA, Kakkar AK. Variation in the relative risk of venous thromboembolism in different cancers. Thromb Haemost 2002
  4. 1076–1077. [CrossRef] 4. Abdel-Razeq HN, Mansour AH, Ismael YM. Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome-a comprehensive cancer center experience. Vasc Health Risk Manag 2011
  5. 153–158. [CrossRef] 5. Stein PD, Fowler SE, Goodman LR, et al. Multi-detector computed tomography for acute pulmonary embolism. N Engl J Med 2006
  6. 2317–2327. [CrossRef] 6. MamLouk MD, van Sonnenberg E, Gosalia R, et al. Pulmonary embolism at CT angiography: implications for appropriateness, cost, and radiation exposure in 2003 patients. Radiology 2010
  7. 625–630. [CrossRef] 7. Verdun FR, Bochud F, Gudinchet F, et al. Radiation risk: what you should know to tell your patient. Radiographics 2008
  8. 28L1807– 1816. 8. Albrecht MH, Bickford MW, Nance JW Jr, et al. State-of-the-art pulmonary CT angiography for acute pulmonary embolism. AJR Am J Roentgenol 2017
  9. 495–504. [CrossRef] 9. McCullough PA, Sandberg KR. Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med 2003
  10. 4 (Suppl 5): S3–S9. 10. Launary-Vacher V, Oudard S, Janus N, et al. Prevalence of renal insufficiency in cancer patients and implications of anticancer drug management. Cancer 2007
  11. 1376–1384. [CrossRef] 11. Pathe C, Eble K, Schmitz-Beuting D, et al. The presence of iodinated contrast agents amplifies DNA radiation damage in computed tomography. Contrast Media Mol Imaging 2011
  12. 507–513. [CrossRef] 12. Piechowlak EI, Peter JFW, Kleb B, et al. Intravenous iodinated contrast agents amplify DNA radiation damage at CT. Radiology 2015
  13. 692–697. [CrossRef] 13. Grudzenski S, Kuefner MA, Heckmann MB, et al. Contrast-medium enhanced radiation damage caused by CT examinations. Radiology 2009
  14. 706–714. [CrossRef] 14. Tao SM, Wichmann JL, Schopef UJ, et al. Contrast induced nephropathy in CT: incidence, risk factors and strategies for prevention. Eur Radiol 2016
  15. 3310–3318. [CrossRef] 15. Wichmann JL, Katzberg RW, Litwin SE, et al. Contrast